(provided by candidate): This proposed 5 year development period will be used for research and training activities that will give Dr. Fox the skills to become an independent investigator. Dr. Fox's long-term career goals are: 1) to develop expertise in evaluating large clinical datasets;2) to generate analyses of the impact of HIV treatment programs;and 3) to develop novel analytic approaches to estimating the impact of HIV programs on clinical and social outcomes. This training will include formal class study, carrying out a research project, and research mentorship from experts in HIV, epidemiology and mathematical modeling. The training will focus on: 1) a thorough understanding HIV management;2) specialized epidemiologic methods;and 3) practical research implementation skills. The primary research project is a study of drop-outs from one of the largest HIV treatment sites in Africa (more than 11,000 patients on antiretroviral therapy), the Themba Lethu Clinic (TLC) in Johannesburg, South Africa. Despite the large scale roll-out of antiretroviral therapy (ART) in 2004 in South Africa, many patients who test HIV-positive never start ART and many who start drop out of care. Information on where in the continuum of care patients are being lost is of vital importance to the success of ART programs.
The aims of this study are: 1): to measure the rates and predictors of losses from TLC;2) to validate TLC mortality data using South Africa's National Death Registry;3) to estimate the effectiveness of ART on mortality;and 4) to estimate the impact of strategies to increase retention on mortality using mathematical modeling. We will conduct a longitudinal cohort study (built on the TLC cohort run by co-mentor Sanne) assessing drop out rates among patients in 3 populations: 1) patients testing HIV-positive;2) patients initiating pre-ART HIV care;and 3) patients on ART. The Therapy Edge(tm) database which is currently being used at TLC will be used to monitor groups 2 and 3. We will enroll subjects in group 1 and will use the database to assess drop-outs from each population. We will conduct a validation study of mortality data for all patients lost to follow-up, and use validated data to assess the effectiveness of ART comparing pre-ART and ART mortality rates using marginal structural models.

Public Health Relevance

To best utilize resources for maintaining patients in HIV care, detailed information is needed on when patients are lost, how we can identify them and what can be done to increase retention. The results of this study will give a complete picture of drop out and mortality from HIV care, what effect treatment programs are having on mortality, and where limited resources for retaining patients could have the greatest impact.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Scientist Development Award - Research & Training (K01)
Project #
5K01AI083097-04
Application #
8306123
Study Section
Acquired Immunodeficiency Syndrome Research Review Committee (AIDS)
Program Officer
Huebner, Robin E
Project Start
2009-09-25
Project End
2014-07-31
Budget Start
2012-08-01
Budget End
2013-07-31
Support Year
4
Fiscal Year
2012
Total Cost
$123,012
Indirect Cost
$9,112
Name
Boston University
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Bohlius, Julia; Valeri, Fabio; Maskew, Mhairi et al. (2014) Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era. Int J Cancer 135:2644-52
Izadnegahdar, Rasa; Fox, Matthew P; Jeena, Prakash et al. (2014) Revisiting pneumonia and exposure status in infants born to HIV-infected mothers. Pediatr Infect Dis J 33:70-2
Takuva, Simbarashe; Maskew, Mhairi; Brennan, Alana T et al. (2014) Poor CD4 recovery and risk of subsequent progression to AIDS or death despite viral suppression in a South African cohort. J Int AIDS Soc 17:18651
Shearer, Kate; Maskew, Mhairi; Ajayi, Toyin et al. (2014) Incidence and predictors of herpes zoster among antiretroviral therapy-naïve patients initiating HIV treatment in Johannesburg, South Africa. Int J Infect Dis 23:56-62
Shearer, Kate; Brennan, Alana T; Maskew, Mhairi et al. (2014) The relation between efavirenz versus nevirapine and virologic failure in Johannesburg, South Africa. J Int AIDS Soc 17:19065
Fox, Matthew P; Shearer, Kate; Maskew, Mhairi et al. (2014) Attrition through multiple stages of pre-treatment and ART HIV care in South Africa. PLoS One 9:e110252
Menezes, C N; Duarte, R; Dickens, C et al. (2013) The early effects of stavudine compared with tenofovir on adipocyte gene expression, mitochondrial DNA copy number and metabolic parameters in South African HIV-infected patients: a randomized trial. HIV Med 14:217-25
Clouse, Kate; Pettifor, Audrey; Maskew, Mhairi et al. (2013) Initiating antiretroviral therapy when presenting with higher CD4 cell counts results in reduced loss to follow-up in a resource-limited setting. AIDS 27:645-50
Johnson, Leigh F; Mossong, Joel; Dorrington, Rob E et al. (2013) Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies. PLoS Med 10:e1001418
Clouse, Kate; Pettifor, Audrey; Shearer, Kate et al. (2013) Loss to follow-up before and after delivery among women testing HIV positive during pregnancy in Johannesburg, South Africa. Trop Med Int Health 18:451-60

Showing the most recent 10 out of 40 publications